$EDSA 8-K SEC Filings

Filed On	Filing
23 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
15 Oct 2026	8-K: Other Events On October 15, 2026, Edesa Biotech, Inc. (the “Company”) reported that the U.S. Food and Drug Administration (“FDA”) has cleared the Company's Investigational New Drug (“IND”) application for its Phase 2 clinical study of EB06 in vitilig...
20 Aug 2026	8-K: Entry into a Material Definitive Agreement; Other Events
13 Aug 2026	8-K: Results of Operations and Financial Condition
11 Jun 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
05 Jun 2026	8-K: Other Events
29 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
15 May 2026	8-K: Departure/Election of Directors or Officers; Compensation
14 May 2026	8-K: Results of Operations and Financial Condition
24 Feb 2026	8-K: Other Events
13 Feb 2026	8-K: Results of Operations and Financial Condition
12 Dec 2025	8-K: Other Events
12 Dec 2025	8-K: Results of Operations and Financial Condition
28 Oct 2025	8-K: Other Events
30 Sep 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
09 Sep 2025	8-K: Other Events
08 Aug 2025	8-K: Results of Operations and Financial Condition
28 May 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
14 May 2025	8-K: Results of Operations and Financial Condition
04 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation; Other Events

Comments